Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination. Continue your routine care with us by scheduling an in-person appointment or Video Visit.
Found 336 results
Dinkin M, Lavi E, Winterkorn J, Oliveira C, Merkler AE.  2019.  Ischemic Optic Neuropathy Secondary to Intravascular Lymphoma.. J Neuroophthalmol. 39(3):313-318.
Andersen BM, Miranda C, Hatzoglou V, DeAngelis LM, Miller AM.  2019.  Leptomeningeal metastases in glioma: The Memorial Sloan Kettering Cancer Center experience.. Neurology. 92(21):e2483-e2491.
Daileda T, Vahidy FS, Chen PRoc, Kamel H, Liang CW, Savitz SI, Sheth SA.  2019.  Long-term retreatment rates of cerebral aneurysms in a population-level cohort.. J Neurointerv Surg. 11(4):367-372.
Roh DJ, Albers DJ, Magid-Bernstein J, Doyle K, Hod E, Eisenberger A, Murthy S, Witsch J, Park S, Agarwal S et al..  2019.  Low hemoglobin and hematoma expansion after intracerebral hemorrhage.. Neurology. 93(4):e372-e380.
Weaver J, Sarva H, Barone D, Bobker S, Bushara K, Hiller A, Ishii M, Jankovic J, Lakhani S, Niotis K et al..  2019.  McLeod syndrome: Five new pedigrees with novel mutations.. Parkinsonism Relat Disord. 64:293-299.
Linkous A, Balamatsias D, Snuderl M, Edwards L, Miyaguchi K, Milner T, Reich B, Cohen-Gould L, Storaska A, Nakayama Y et al..  2019.  Modeling Patient-Derived Glioblastoma with Cerebral Organoids.. Cell Rep. 26(12):3203-3211.e5.
Luo L, Andrews H, Alcalay RN, Poyraz FCarvalho, Boehme AK, Goldman JG, Xie T, Tuite P, Henchcliffe C, Hogarth P et al..  2019.  Motor phenotype classification in moderate to advanced PD in BioFIND study.. Parkinsonism Relat Disord. 65:178-183.
Zhang S, Chiang GChia-Yi, Magge RS, Fine HAlan, Ramakrishna R, Chang EWang, Pulisetty T, Wang Y, Zhu W, Kovanlikaya I.  2019.  MRI based texture analysis to classify low grade gliomas into astrocytoma and 1p/19q codeleted oligodendroglioma.. Magn Reson Imaging. 57:254-258.
Ivanidze J, Lum M, Pisapia D, Magge R, Ramakrishna R, Kovanlikaya I, Fine HA, Chiang GC.  2019.  MRI Features Associated with TERT Promoter Mutation Status in Glioblastoma.. J Neuroimaging. 29(3):357-363.
Omran SSalehi, Chatterjee A, Chen ML, Lerario MP, Merkler AE, Kamel H.  2019.  National Trends in Hospitalizations for Stroke Associated With Infective Endocarditis and Opioid Use Between 1993 and 2015.. Stroke. 50(3):577-582.
Sandrone S, Berthaud JV, Chuquilin M, Cios J, Ghosh P, Gottlieb-Smith RJ, Kushlaf H, Mantri S, Masangkay N, Menkes DL et al..  2019.  Neurologic and neuroscience education: Mitigating neurophobia to mentor health care providers.. Neurology. 92(4):174-179.
Reshef ER, Schiff ND, Brown EN.  2019.  A Neurologic Examination for Anesthesiologists: Assessing Arousal Level during Induction, Maintenance, and Emergence.. Anesthesiology. 130(3):462-471.
Victor JD, Boie SD, Connor EG, Crimaldi JP, G Ermentrout B, Nagel KI.  2019.  Olfactory Navigation and the Receptor Nonlinearity.. J Neurosci. 39(19):3713-3727.
VanderPluym JH, Hamilton K, Hindiyeh NA, Robbins MS, Starling AJ, Vargas BB, Gibbons SK, Vgontzas A.  2019.  Online Migraine Education and Support for Patients: Perspectives from the American Headache Society Emerging Leaders Program.. Headache. 59(9):1656-1658.
Michel M, Beck D, Block N, Blumenfeld H, Brown R, Carmel D, Carrasco M, Chirimuuta M, Chun M, Cleeremans A et al..  2019.  Opportunities and challenges for a maturing science of consciousness.. Nat Hum Behav. 3(2):104-107.
Perumal J, Fox RJ, Balabanov R, Balcer LJ, Galetta S, Makh S, Santra S, Hotermans C, Lee L.  2019.  Outcomes of natalizumab treatment within 3 years of relapsing-remitting multiple sclerosis diagnosis: a prespecified 2-year interim analysis of STRIVE.. BMC Neurol. 19(1):116.
Julie DAR, Ahmed Z, Karceski SC, Pannullo SC, Schwartz TH, Parashar B, A Wernicke G.  2019.  An overview of anti-epileptic therapy management of patients with malignant tumors of the brain undergoing radiation therapy.. Seizure. 70:30-37.
Lin M-H, Kamel H, Singer DE, Wu Y-L, Lee M, Ovbiagele B.  2019.  Perioperative/Postoperative Atrial Fibrillation and Risk of Subsequent Stroke and/or Mortality.. Stroke. 50(6):1364-1371.
Cabrera LY, Sarva H, Sidiropoulos C.  2019.  Perspectives on the Earlier Use of Deep Brain Stimulation for Parkinson Disease from a Qualitative Study of U.S. Clinicians.. World Neurosurg. 128:e16-e20.
Kang Y, Gauthier SA.  2019.  PET is necessary to make the next step forward in understanding MS pathophysiology - Commentary.. Mult Scler. 25(8):1090-1091.
Shafiq ARaza, A Wernicke G, Riley CAlex, Morgenstern PF, Nedialkova L, Pannullo SC, Parashar B, Magge R, Schwartz TH.  2019.  Placement of cesium-131 permanent brachytherapy seeds using the endoscopic endonasal approach for recurrent anaplastic skull base meningioma: case report and technical note.. J Neurosurg. :1-6.
Eruysal E, Ravdin L, Kamel H, Iadecola C, Ishii M.  2019.  Plasma lipocalin-2 levels in the preclinical stage of Alzheimer's disease.. Alzheimers Dement (Amst). 11:646-653.
Mandava P, Murthy SB, Shah N, Samson Y, Kimmel M, Kent TA.  2019.  Pooled analysis suggests benefit of catheter-based hematoma removal for intracerebral hemorrhage.. Neurology. 92(15):e1688-e1697.
Lee G, Nho K, Kang B, Sohn K-A, Kim D.  2019.  Predicting Alzheimer's disease progression using multi-modal deep learning approach.. Sci Rep. 9(1):1952.
Fridman EA, Osborne JR, Mozley PD, Victor JD, Schiff ND.  2019.  Presynaptic dopamine deficit in minimally conscious state patients following traumatic brain injury.. Brain. 142(7):1887-1893.